Patent · US Active

Controlled release composition

US8101205B2 · kind B2 · utility

4Cited by
16References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2008
Grant dateJan 24, 2012
Priority date
Expiry dateMar 5, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the field of pharmacology. More specific, the invention relates to a controlled release composition.This invention is related to a controlled release composition comprising a cross-linked gelatin and at least one therapeutic protein wherein the ratio of the average mesh size (ξ) of the gelatin matrix and the average hydrodynamic radius (RH) of the therapeutic protein is smaller than 2, preferably smaller than 1.5.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.